» Articles » PMID: 15221580

Chemotherapy-induced Alopecia: Psychosocial Impact and Therapeutic Approaches

Overview
Specialties Critical Care
Oncology
Date 2004 Jun 29
PMID 15221580
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Despite advances in the treatment of many side effects associated with chemotherapy, alopecia remains an issue that is difficult to resolve. Chemotherapy-induced alopecia (CIA) is a condition that can have profound psychosocial and quality-of-life consequences, resulting in anxiety, depression, a negative body image, lowered self-esteem, and a reduced sense of well-being. Patients who fear CIA may sometimes select regimens with less favorable outcomes or may refuse treatment. When supporting patients with CIA, health care providers should use an individualized approach with a focus placed on the actual moment of hair loss. Education, support groups, and self-care strategies are important components of any management approach. No treatment modality for preventing CIA has been clearly shown to be effective. Recent evidence suggests that new scalp hypothermic regimens may be safe and effective. There remains a critical need for effective new approaches to this problem.

Citing Articles

Appearance-related needs and challenges among cancer patients undergoing systemic therapy: a comprehensive survey study.

Ono M, Nagasaki R, Nakamura M, Hamaguchi K, Yokoi M, Matsuura N Int J Clin Oncol. 2025; 30(3):469-479.

PMID: 39891884 DOI: 10.1007/s10147-025-02705-5.


Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.

Chen X, Sun H, Yang C, Wang W, Lyu W, Zou K PeerJ. 2024; 12:e17419.

PMID: 38912044 PMC: 11192027. DOI: 10.7717/peerj.17419.


Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia.

Tsuji T, Yoneda K, Igawa Y, Minamino E, Otani N, Yoshida Y Cancer Chemother Pharmacol. 2024; 94(3):467-473.

PMID: 38642149 DOI: 10.1007/s00280-024-04669-1.


The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India - Multi-centre Retrospective Cohort Study.

Mekha M, Joshi A, Maniar V, Maheshwari U, Joshi K, Kalaskar P Indian J Dermatol. 2024; 69(1):16-23.

PMID: 38572038 PMC: 10986862. DOI: 10.4103/ijd.ijd_345_23.


Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study.

Landeiro L, Miranda D, Machado R, Dienstmann R, Silva M, da Silva C Sci Rep. 2023; 13(1):19555.

PMID: 37945813 PMC: 10636030. DOI: 10.1038/s41598-023-46840-3.


References
1.
. The symptom experience of alopecia. Semin Oncol Nurs. 1995; 11(4):235-8. DOI: 10.1016/s0749-2081(05)80003-8. View

2.
Hidalgo M, Rinaldi D, Medina G, Griffin T, Turner J, Von Hoff D . A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. Anticancer Drugs. 1999; 10(4):393-5. DOI: 10.1097/00001813-199904000-00007. View

3.
Pesce A, Cassuto J, Joyner M, Dujardin P, AUDOLY P . Scalp tourniquet in the prevention of chemotherapy-induced alopecia. N Engl J Med. 1978; 298(21):1204-5. DOI: 10.1056/nejm197805252982121. View

4.
Tierney A, Taylor J . Chemotherapy-induced hair loss. Nurs Stand. 1991; 5(38):29-31. DOI: 10.7748/ns.5.38.29.s39. View

5.
Kiebert G, Hanneke J, de Haes C, Kievit J, van de Velde C . Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer. 1990; 26(10):1038-42. DOI: 10.1016/0277-5379(90)90046-v. View